Health-related quality of life at 3 months following head and neck cancer treatment is a key predictor of longer-term outcome and of benefit from using the patient concerns inventory.

ABSTRACT:

Introduction

During clinical follow-up it can be difficult to identify those head and neck cancer (HNC) patients who are coping poorly and could benefit from additional support. Health-related quality of life (HRQOL) questionnaires and prompt lists provide a means by which patients can express their perceived outcomes and raise concerns. The first aim of this secondary analysis following a randomized trial was to explore which patient characteristics, at around 3 months following treatment completion (baseline), best predict HRQOL 12 months later. The second aim was to attempt to ascertain which patients were most likely to benefit from using prompt list.

Methods

Cluster-controlled pragmatic trial data were analyzed. HRQOL was measured by the University of Washington Quality

SUBMITTER: Kanatas A 

PROVIDER: S-EPMC9041072 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature